Dr. Reddy’s Laboratories (DRL), on Tuesday, reported a 66.58 per cent increase in net profit to Rs.570.9 crore for the fourth quarter of 2012-13 from Rs.342.7 crore in the previous year, due to healthy sales from North America and emerging markets in the company’s global generics segment, apart from improved performance in the pharma services and active ingredients (PSAI) segment.
For 2012-13, DRL’s consolidated net profit was Rs.1,677.6 crore, up 17.62 per cent from Rs.1,426 crore. Revenues were estimated at Rs.11,626.6 crore against Rs.9,673.7 crore, up 20.18 per cent. Revenues from the global general segment were Rs.8.260 crore, a growth of 18 per cent year-on-year.
DividendADVERTISEMENT
ADVERTISEMENT
The board of directors has recommended a final dividend of Rs.15 per share of Rs.5 face value for 2012-13. A dividend of Rs.13.75 per share was paid for 2011-12.
The growth in North America was largely driven by key limited competition products such as ziprasidone, fondaparinux and the ramp-up of the antibiotics portfolio and products from the Shreveport, U.S. facility, said K. Satish Reddy, Vice-Chairman and Managing Director said while announcing the results at a press conference here.
The company was looking at dosage forms such as ‘injectables’ to grow in the North America market, a geography where OTC (over-the-counter) too was a big segment that would witness continued investment of resources, said Chairman, G. V. Prasad.
ADVERTISEMENT
He said they were garnering OTC revenues from India too, but on a different scale. At present, OTC sale contributed 34 per cent of the company’s annual sales.
Mr. Prasad said the company collaborated with Merck Serono, part of the Germany-based Merch KGaA, for developing and commercialising ‘bio-similars’ last year.
Rs.7.40 dividend from Reliance Infra
Reliance Infrastructure has reported a consolidated net profit of Rs.725 crore for the quarter ended March 31, 2013, against Rs.411 crore in the corresponding quarter of the previous year, up 76 per cent.
Total operating income was down at Rs.6,187 crore against Rs.7,135 crore.
For the whole of 2012-13, the company reported a consolidated net profit of Rs.2,247 crore against Rs.1,587 crore in the previous year, up 42 per cent. Cash profit increased by 24 per cent to Rs.2,912 crore from Rs.2,342 crore. Total operating income was down at Rs.22,382 crore against Rs.24,216 crore.
The board has recommended dividend of Rs.7.40 per share for 2012-13.
On a standalone basis, Reliance Infrastructure has reported a lower net profit Rs.599 crore for the fourth quarter ended March 31, 2013, as compared to Rs.658 crore in the corresponding quarter of the previous year.
For the year ended March 31, 2013, its standalone net profit has come down to Rs.1,999.52 crore from Rs.2000.26 crore in the previous year.